Though IgA responses may show poorer durability than IgG (88, 89), taken together with prior studies of other CoV in humans and animals (35–40), these data raise the possibility that levels of SARS-CoV-2-specific mucosal IgA could serve as a useful immune correlate for mitigated disease severity, protection from infection, and reduced likelihood of transmission. Here, CD79A is linked to infection.